BMI OrganBank
PrivateLast Round
Grant
Apr 27, 2026
Total Funding Raised
$3.75M
Company Overview
BMI OrganBank operates in Healthcare & Life Sciences and is based in Winston-Salem, North Carolina. Its latest recorded funding round was a Grant round in April 2026.
BMI OrganBank is a medical device company that develops advanced organ and tissue perfusion and preservation technologies to improve transplant outcomes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BMI OrganBank Comparables
Compare BMI OrganBank with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bridge to Life | 87% | |
| Vascular Perfusion Solutions | 84% | |
| Shanghai Genext Medical Technology Co., Ltd. | 82% |
For institutional investors. Book with your work email.
BMI OrganBank Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 27, 2026 | ||||
| Grant | Nov 19, 2024 | ||||
| Seed | Oct 25, 2023 | ||||
| Debt | Oct 25, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BMI OrganBank Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sonnerie VC | Seed |
| RegenMed Engine | Grant |
| North Carolina Biotechnology Center | Debt, Seed |
| TCA Venture Group | Seed |
| National Institutes of Health (NIH) | Grant |
| Band of Angels | Seed |
| Golden Seeds | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2025
Grew 20% QoQ, from 20 to 24 employees.
- Jan 25, 2025
Grew 18% QoQ, from 17 to 20 employees.
For institutional investors. Book with your work email.
BMI OrganBank Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BMI OrganBank's valuation, stock price, and market status.
Is BMI OrganBank a public or private company?
BMI OrganBank is a private company.
What is the current stock price of BMI OrganBank?
BMI OrganBank is a private company, so its shares have no public market price. Caplight tracks BMI OrganBank's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BMI OrganBank worth (valuation)?
Valuation information for BMI OrganBank is not publicly available.
Can I buy BMI OrganBank stock?
BMI OrganBank shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BMI OrganBank's last funding round?
BMI OrganBank's most recent funding round was Grant on April 27, 2026.
Who are the main investors in BMI OrganBank?
Key investors in BMI OrganBank include Sonnerie VC, RegenMed Engine, North Carolina Biotechnology Center, TCA Venture Group, National Institutes of Health (NIH).
Will BMI OrganBank IPO soon?
No public IPO plans have been announced for BMI OrganBank.
How can I track BMI OrganBank secondary market activity?
Caplight tracks bids, offers, and trades in BMI OrganBank's shares on secondary markets.